Silence Therapeutics Cash Flow Statement (2021-2026) | SLN

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -2.31M-19.75M-35.54M12.30M-28.53M-27.35M-20.96M-12.85M-14.96M
Depreciation and Depletion (Quarter) 0.09M0.09M0.09M0.04M0.07M0.08M0.08M0.08M0.07M
Share-based Compensation (Quarter) 4.12M4.14M4.07M3.98M3.54M2.08M2.54M-0.09M2.45M
Deferred Taxes (Quarter) 0.24M0.23M0.05M0.32M0.01M0.00M
Gains from Investment Securities (Quarter) 3.62M13.57M6.56M-0.02M-0.26M-0.05M7.13M7.34M7.03M0.42M7.43M-0.09M
Non-cash Items (Quarter) 2.22M3.00M2.87M3.41M3.71M3.98M4.21M4.50M
Cash from Operations (Quarter) -9.14M-5.41M-25.61M-27.48M-12.31M-21.78M-10.91M-17.27M-15.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.06M0.06M0.07M0.06M0.07M0.07M0.07M0.04M0.03M
Depreciation & Amortization (CF) (Quarter) 0.09M0.09M0.09M0.04M0.07M0.08M0.08M0.08M0.07M
Change in Working Capital
Change in Receivables (Quarter) 10.01M-7.97M-1.75M0.61M-0.94M0.01M-0.06M-0.03M
Other Working Capital Changes (Quarter) 0.77M-4.71M5.66M-30.51M0.59M-3.02M2.28M-0.02M-0.02M
Investing Activities
Capital Expenditures (Quarter) 0.09M0.06M0.06M0.00M0.05M0.00M
Cash from Investing Activities (Quarter) -49.91M-0.04M-38.14M66.12M-44.38M-1.56M51.29M-53.34M10.00M
Financing Activities
Cash from Financing Activities (Quarter) 133.02M1.19M7.97M-0.10M0.01M0.00M
Additional items
Exchange Rate Effect (Quarter) -0.04M-0.01M0.27M-0.16M0.23M0.20M-0.11M-0.13M-0.02M
Change in Cash (Quarter) 73.97M-4.26M-55.77M38.55M-56.68M-23.34M40.40M-70.62M-5.60M
Free Cash Flow (Quarter) -9.14M-5.49M-25.67M-27.54M-12.31M-21.83M-10.91M-17.27M-15.60M
Net Cash Flow (Quarter) 73.97M-4.26M-55.77M38.55M-56.68M-23.34M40.38M-70.61M-5.60M